Skip to main content
. 2018 Dec 5;4(2):78–82. doi: 10.1136/svn-2018-000198

Table 1.

Loss-of-function studies on major BM components

Genes Knockout/mutation Cre promoter Knockout phenotype References
Collagen IV
 Collagen 4A1/2 Global knockout BM structural deficiencies and embryonic lethality (E10.5–E11.5) 39
 Collagen 4A1 Lacking exon 41 in both alleles Embryonic lethality 45
 Collagen 4A1 Lacking exon 41 in one allele Intracerebral haemorrhage and porencephaly 40 41
 Collagen 4A1 Conditional knockout Rosa26-CreER, Tie2-Cre, Pdgfrb-Cre, Gfap-Cre Intracerebral haemorrhage and porencephaly with different severity 42
 Collagen 4A1/2 Missense mutations Vascular defects and brain malformations 43 44
 Collagen 4A2 Missense mutations Intracerebral haemorrhage 45
Laminin
 Laminin α2 Global knockout BBB disruption 58
 Laminin α4 Global knockout Haemorrhage during embryonic/neonatal stage 68
 Laminin α5 Global knockout Embryonic lethality (~E17) and defects in neural tube closure and neural crest cell migration 52–54
Conditional knockout Tie2-Cre
(endothelium)
No gross CNS abnormalities under homeostatic conditions 70 71
 Laminin β1 Global knockout Embryonic lethality (E5.5–E6.5) 55
 Laminin γ1 Global knockout Embryonic lethality (E5.5–E6.5) 55–57
Conditional knockout Nestin-Cre (neural progenitors) BBB breakdown and intracerebral haemorrhage 1 87
Conditional knockout Pdgrfb-Cre (mural cells) Hydrocephalus and BBB breakdown 51
Nidogen
 Nidogen-1 Global knockout Mild BM alteration in brain capillaries 72–74
 Nidogen-2 Global knockout No effect on BM formation 75
 Nidogen-1 and nidogen-2 Global knockout BM defect and perinatal lethality 77–79
Perlecan
 Perlecan Global knockout Embryonic lethality (E10–E12) 84–86

BBB, blood–brain barrier; BM, basement membrane; CNS, central nervous system.